Hacked by islam_Bey imhatimi.org

Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 25, 2008, inter alia, has approved issue of secured Non Convertible Debentures (NCD) on private placement basis to the extent of Rs 300 Crores on such terms and conditions as may be mutually agreed upon with the lenders / subscribers of the NCDs in compliance with the Guidelines issued by SEBI and other regulatory requirements for issue of Debentures.

Sterling Biotech Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on June 02, 2008, inter alia, have accorded the following:

1. Considered, approved and adopted the Audited Accounts of the Company for the year ended December 31, 2007.

2. Declared a dividend @ 50% (Re 0.50 per Equity Share of Re 1/- each) for the year ended December 31, 2007.

3. Re-appointed Mr. C J Sandesara and Mr. N B Patel as Directors of the Company.

4. Re-appointed M/s. H S Hathi & Co., Chartered Accountants, Mumbai, as Auditors of the Company to hold office from the conclusion of this Annual General Meeting till the conclusion of the next Annual General Meeting, on remuneration, terms & conditions as may be decided by the Board.

Sterling Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from May 26, 2008 to June 02, 2008 (both days inclusive) for the purpose of payment of dividend & 22nd Annual General Meeting (AGM) of the Company to be held on June 02, 2008.

Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2008, inter alia, has recommended 50% (Rs 0.50 per equity shares of FV of Rs 1/-) dividend on the equity shares for the financial year ended December 31, 2007 subject to approval of the members.

Sterling Biotech Ltd has informed BSE that following Companies are now part of the Promoters Group of the Company with effect from March 28, 2008 as detailed below;

1. Eminence Trading Pvt Ltd holds 19,19,000 equity shares (representing 0.84% of the Company).

2. Antariksha Securities Pvt Lid holds 19,50,000 equity shares (representing 0.85% of the Company).

3. Marut Apparels Pvt Ltd holds 18,85,000 equity shares (representing 0.82% of the Company).

With the above, promoters group shareholding stands at 8,90,34,694 equity shares of Rs 1/- each representing 38.80% of capital of the Company.

Sterling Biotech Ltd has informed BSE that following Companies are now part of the Promoters Group of the Company with effect from March 27, 2008 as detailed below:

1. Swadeshi Finvest Pvt. Ltd. holds 15,38,000 equity shares (representing 0.67% of Sterling Biotech Equity Capital).

2. Sealord Erections Pvt. Ltd. holds 18,70,000 equity shares (representing 0.81% of Sterling Biotech Equity Capital).

3. Antariksha Capital and Finance (India) Pvt. Ltd. holds 19,00,000 equity shares (representing 0.83% of Sterling Biotech Equity Capital).

With the above Companies now being part of the promoters group shareholding of promoters group stands at 8,32,80,694 equity shares of Rs 1/- each representing 36.29% of equity capital of the Company.

Sterling Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 31, 2008, to consider Audited accounts for the year ending December 31, 2007 and also to consider the declaration of Dividend subject to the final approval of the members at the Annual General Meeting.

Sterling Biotech Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on March 05, 2008, have unanimously passed the following special resolutions:

1. Re-appointment of Shri. Nitin J Sandesara as Managing Director of the Company for 5 years upto February 28, 2013.

2. Enabling resolution for Sponsored ADR, GDR, FCCB, etc to the extent of USD 250 Million.

3. Enabling resolution for Issue of ADR, GDR, FCCB, etc. to the extent of USD 250 Million.